Ming Zi Chen
Vorstandsvorsitzender bei WuXi Biologics Germany GmbH
Profil
Ming Zi Chen is currently the Co-Managing Director at WuXi Biologics Germany GmbH and the Chief Business Officer at InSilico Medicine Cayman TopCo. Chen holds a doctorate degree from the University of Washington.
Aktive Positionen von Ming Zi Chen
| Unternehmen | Position | Beginn |
|---|---|---|
WuXi Biologics Germany GmbH
 WuXi Biologics Germany GmbH BiotechnologyHealth Technology Part of Wuxi Biologics (Cayman), Inc., WuXi Biologics Germany GmbH is a company that engages in the development and manufacturing of biologics. The company is based in Leverkusen, Germany. The CEOs of the company are Zhisheng Chen, Jian Dong, Ming Zi Chen. | Vorstandsvorsitzender | - |
Insilico Medicine Cayman TopCo
 Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | Corporate Officer/Principal | 01.10.2021 |
Ausbildung von Ming Zi Chen
| University of Washington | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Insilico Medicine Cayman TopCo
Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | Commercial Services |
WuXi Biologics Germany GmbH
WuXi Biologics Germany GmbH BiotechnologyHealth Technology Part of Wuxi Biologics (Cayman), Inc., WuXi Biologics Germany GmbH is a company that engages in the development and manufacturing of biologics. The company is based in Leverkusen, Germany. The CEOs of the company are Zhisheng Chen, Jian Dong, Ming Zi Chen. | Health Technology |